Proteomic insights into non-small cell lung cancer: New ideas for cancer diagnosis and therapy from a functional viewpoint

•Combined 2D-DIGE analysis of two different lung cancer subtypes (SCC and AC) and cultured cells.•Specific analysis of the Sec62 interactome by co- immunoprecipitation.•Plastin-3 and Vimentin are differentially abundant in all proteomic screens.•The results hint toward a Sec62- and Ca2+-dependent actin remodeling.•This suggests an explanation for Sec62's influence on tumor cell migration.

We recently characterized SEC62 as an oncogene in non-small-cell lung cancer (NSCLC). Here we aimed to gain further insight into the molecular mechanisms of the cancer-related functions of this oncogene. We performed 2D-DIGE proteome analysis of tumor material from patients with NSCLC and of HEK293 cells stably overexpressing plasmid-encoded SEC62, combined with investigation of the Sec62 interactome. Furthermore, we analyzed the proteomic effects of siRNA-mediated depletion of the Sec62-interacting protein Sec63. We identified a comprehensive list of differentially regulated proteins, providing new insights into the molecular mechanisms of the cancer-related functions of Sec62 in cell migration, drug resistance, and Ca2+-homeostasis.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide